+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Migraine Therapeutics Market 2021-2025- Product Image

Global Migraine Therapeutics Market 2021-2025

  • ID: 5309585
  • Report
  • March 2021
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly and Co.
  • eNeura Inc.
  • GlaxoSmithKline Plc
  • Grunenthal GmbH
  • MORE
Global Migraine Therapeutics Market 2021-2025

The publisher has been monitoring the migraine therapeutics market and it is poised to grow by $ 1.06 bn during 2021-2025 progressing at a CAGR of 5% during the forecast period. The report on migraine therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increase in the number of patients suffering from migraine and rise in the number of approvals for preventive drugs for migraine. In addition, increase in the number of patients suffering from migraine is anticipated to boost the growth of the market as well.

The migraine therapeutics market analysis includes product segment and geographical landscapes.

The migraine therapeutics market is segmented as below:

By Product
  • drugs
  • devices
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies the rising advances in migraine therapeutics as one of the prime reasons driving the migraine therapeutics market growth during the next few years.

The report on migraine therapeutics market covers the following areas:
  • Migraine therapeutics market sizing
  • Migraine therapeutics market forecast
  • Migraine therapeutics market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading migraine therapeutics market vendors that include AbbVie Inc., Amgen Inc., Eli Lilly and Co., eNeura Inc., GlaxoSmithKline Plc, Grunenthal GmbH, H. Lundbeck AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Upsher-Smith Laboratories LLC. Also, the migraine therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly and Co.
  • eNeura Inc.
  • GlaxoSmithKline Plc
  • Grunenthal GmbH
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Drugs - Market size and forecast 2020-2025
  • Devices - Market size and forecast 2020-2025
  • Market opportunity by Product
Market Segmentation by Treatment
  • Preventive treatment
  • Abortive treatment
Customer landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • Asia - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
  • Competitive scenario
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly and Co.
  • eNeura Inc.
  • GlaxoSmithKline Plc
  • Grunenthal GmbH
  • H. Lundbeck AS
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Upsher-Smith Laboratories LLC
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Product - Market share 2020-2025 (%)
  • Comparison by Product
  • Drugs - Market size and forecast 2020-2025 ($ million)
  • Drugs - Year-over-year growth 2020-2025 (%)
  • Devices - Market size and forecast 2020-2025 ($ million)
  • Devices - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Product
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • Asia - Market size and forecast 2020-2025 ($ million)
  • Asia - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc. - Overview
  • AbbVie Inc. - Business segments
  • AbbVie Inc. - Key offerings
  • AbbVie Inc. - Key customers
  • AbbVie Inc. - Segment focus
  • Amgen Inc. - Overview
  • Amgen Inc. - Business segments
  • Amgen Inc. - Key offerings
  • Amgen Inc. - Key customers
  • Amgen Inc. - Segment focus
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Business segments
  • Eli Lilly and Co. - Key offerings
  • Eli Lilly and Co. - Key customers
  • Eli Lilly and Co. - Segment focus
  • eNeura Inc. - Overview
  • eNeura Inc. - Product and service
  • eNeura Inc. - Key offerings
  • eNeura Inc. - Key customers
  • eNeura Inc. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Grunenthal GmbH - Overview
  • Grunenthal GmbH - Product and service
  • Grunenthal GmbH - Key offerings
  • Grunenthal GmbH - Key customers
  • Grunenthal GmbH - Segment focus
  • H. Lundbeck AS - Overview
  • H. Lundbeck AS - Business segments
  • H. Lundbeck AS - Key offerings
  • H. Lundbeck AS - Key customers
  • H. Lundbeck AS - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Key customers
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • Upsher-Smith Laboratories LLC - Overview
  • Upsher-Smith Laboratories LLC - Product and service
  • Upsher-Smith Laboratories LLC - Key offerings
  • Upsher-Smith Laboratories LLC - Key customers
  • Upsher-Smith Laboratories LLC - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly and Co.
  • eNeura Inc.
  • GlaxoSmithKline Plc
  • Grunenthal GmbH
  • MORE
The publisher recognizes the following companies as the key players in the global migraine therapeutics market: AbbVie Inc., Amgen Inc., Eli Lilly and Co., eNeura Inc., GlaxoSmithKline Plc, Grunenthal GmbH, H. Lundbeck AS, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Upsher-Smith Laboratories LLC.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising advances in migraine therapeutics.'

According to the report, one of the major drivers for this market is the increase in the number of patients suffering from migraine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
4 of 5
  • AbbVie Inc.
  • Amgen Inc.
  • Eli Lilly and Co.
  • eNeura Inc.
  • GlaxoSmithKline Plc
  • Grunenthal GmbH
  • H. Lundbeck AS
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Upsher-Smith Laboratories LLC
Note: Product cover images may vary from those shown
5 of 5

Loading
LOADING...

Adroll
adroll